Potent inhibition of tumor survival in vivo by β-lapachone plus taxol: Combining drugs imposes different artificial checkpoints

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 23, 1999, Pages 13369-13374

  Li, Chiang J ^a,b   Li, You Zhi ^a,b   Pinto, Antonio Ventura ^c   Pardee, Arthur B ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA LAPACHONE; PACLITAXEL; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE; CELL DEATH; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL SURVIVAL; CYCLIN-DEPENDENT KINASES; DRUG SYNERGISM; FEMALE; HUMANS; MICE; MICE, NUDE; NAPHTHOQUINONES; OVARIAN NEOPLASMS; PACLITAXEL; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033539487     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.23.13369     Document Type: Article

References (26)

1. Evan, G. & Littlewood, T. (1998) Science 81, 1317-1322.
2. Fingert, H. J., Chang, J. D. & Pardee, A. B. (1986) Cancer Res. 46, 2463-2467.
3. Hartwell, L. H. & Kastan, M. B. (1994) Science 266, 1821-1828.
4. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W. & Vogelstein, B. (1998) Science 282, 1497-1501.
5. Sorger, P. K., Dobles, M., Tournebize, R. & Hyman, A. A. (1997) Curr. Opin. Cell Biol. 9, 807-814.
6. Wahl, A. F., Donaldson, K. L., Fairchild, C., Lee, F. Y., Foster, S. A., Demers, G. W. & Galloway, D. A. (1996) Nat. Med. 2, 72-79.
7. Trielli, M. O., Andreassen, P. R., Lacroix, F. B. & Margolis, R. L. (1996) J. Cell Biol. 135, 689-700.
8. Woods, C. M., Zhu, J., McQueney, P. A., Bollag, D. & Lazarides, E. (1995) Mol. Med. 1, 506-526.
9. Hooker, S. C. (1936) J. Am. Chem. Soc. 58, 1181-1190.
10. Goncalves de Lima, O., D'Albuquerque, I. L., Goncalves de Lima, C. & Dalia Maia, M. H. (1962) Rev. Inst. Antibiol. (Recife) 4, 3-17.,
11. Li, Y.-Z., Li, C. J., Pinto, V. A. & Pardee, A. B. (1999) Mol. Med. 5, 232-239.
12. Wuerzberger, S. M., Pink, J. J., Planchon, S. M., Byers, K. L., Bornmann, W. G. & Boothman, D. A. (1998) Cancer Res. 58, 1876-1885.
13. Shiah, S. G., Chuang, S. E., Chau, Y. P., Shen, S. C. & Kuo, M. L. (1999) Cancer Res. 59, 391-398.
14. Li, C. J., Friedman, D. J., Wang, C., Metelev, V. & Pardee, A. B. (1995) Science 268, 429-431.
15. Li, C. J., Wang, C. & Pardee, A. B. (1995) Cancer Res. 55, 3712-3715.
16. Fadok, V. A, Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L. & Henson, P. M. (1992) J. Immunol. 148, 2207-2216.
17. Strobel, T., Swanson, L. & Cannistra, S. A. (1997) Cancer Res. 57, 1228-1232.
18. Li, C. J., Wang, C., Friedman, D. J. & Pardee, A. B. (1995) Proc. Natl. Acad. Sci. USA 92, 5461-5412.
19. Elledge, S. J. (1996) Science 274, 1664-1672.
20. Nurse, P. (1997) Cell 91, 865-867.
21. Sherr, C. J. & Roberts, J. M. (1999) Genes Dev. 13, 1501-1512.
22. Borodyansky, B., Li, Y.-Z., Pardee, A. B. & Li, C. J. (1998) Apoptosis 3, 381-385.
23. Schlegel, R. & Pardee, A. B. (1986) Science 232, 1264-1266.
24. Pardee, A. B. (1989) Science 3, 603-608.
25. Hartwell, L. H. & Weinert, T. A. (1989) Science 246, 629-634.
26. Levine, A. J. (1997) Cell 88, 323-331.